The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, mentorship, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

Novel Coronavirus / COVID-19 Resources

The INS Peer-Reviewed Journal

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online. The journal also has social media accounts on Twitter, Facebook, and Instagram.

journal cover

+Submit a Manuscript.+


What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Review and Meta-Analysis Compares Spinal Cord Stimulation Waveforms for Treating Chronic Low Back Pain

Sept. 23, 2020 - A systemic review and meta-analysis gathered evidence for various spinal cord stimulation waveforms -- tonic, burst, and high-frequency -- relative to each other for treating chronic refractory low back pain. The analysis included randomized controlled trials and prospective cohort studies; the authors there were some heterogeneity and limitations in evidence, and that evidence of longitudinal efficacy is needed for the more-novel waveforms. (Source: Pain Physician)

Pilot Study Will Use Accelerated Approach to Transcranial Magnetic Stimulation

Sept. 22, 2020 - Nexstim Plc announced a pilot study for a new treatment protocol for severe depression is starting in Finland. In it, intermittent theta burst magnetic stimulation is given several times a day for one week, rather than a conventional approach in which transcranial magnetic stimulation is given once a day for several weeks. (Source: Globe Newswire)

Review Includes Peripheral Nerve Stimulation for Acute Post-Operative Pain

September 2020 - A review about two types of regional analgesia for acute post-operative pain that are "free of many of the limitations of both opioids and local anesthetic-based techniques" includes percutaneous peripheral nerve stimulation, saying it is "unique . . . in that it does not induce sensory, motor, or proprioception deficits and is cleared for up to 60 days of use." The review, however, calls for additional validation in the setting of acute pain through randomized controlled trials of the two non-pharmaceutical methods it covers. (Source: Anesthesiology)

Laboratory Study Provides Insight into Neuronal Effects of Ultrasound Neuromodulation

Sept. 18, 2020 - A laboratory study in a transgenic mouse brain slice model to determine effective parameters to elicit neuromodulation through ultrasound showed its application increased calcium signaling, the neuronal response rate depended on pulse repetition frequency, and it reversed effects of a sodium channel blocker. (Source: Scientific Reports)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs

SAVE THE DATE: International Neuromodulation Society 3rd Interim Meeting, Nov. 19-21, 2021, Mumbai, India